why choose us

Clinical Trials Search

Showing 7,430 of 132,963 result(s)
Is There an Association Between Quadriceps Strength and Different Markers of Fragility in Patients With Cirrhosis?

Status: COMPLETED

Condition: Cirrhosis

Interventions: Assessments for all patients : isometric quadriceps strength, malnutrition by RFH-NPT and MNA questionnaires, body composition by circumference and tr

Date: 2023-10-31

Shaping the Indications for Periodontal Adjunctive Antibiotics in Dental Practice

Status: COMPLETED

Condition: Periodontitis

Interventions: Amoxicillin belongs to the penicillin category, and it is a commonly prescribed broad-spectrum antibiotic as a periodontal treatment adjunct.

Date: 2023-10-31

BEP Targeting Strategies in Ethiopia

Status: COMPLETED

Condition: Small for Gestational Age at Delivery
Gestational Weight Gain
Stillbirth
Preterm Birt

Interventions: DIETARY_SUPPLEMENT: Targeted BEP based on baseline nutritional status - In Arm 2 (targeted BEP based on baseline nutritional status), in addition to t

Date: 2023-10-31

Respiratory Sarcopenia in Institutionalized Older Adults in the Region of Murcia

Status: COMPLETED

Condition: Sarcopenia

Interventions:

Date: 2023-10-30

A Real-world, Multi-center, Prospective, Observational Study for PNH in China

Status: COMPLETED

Condition: Paroxysmal Nocturnal Hemoglobinuria

Interventions:

Date: 2023-10-30

A Phase 1 Study to Evaluate the Safety, Tolerability, PK;PD of SRSD107 in Healthy Participants

Status: COMPLETED

Condition: Thrombosis

Interventions: SRSD107 is a synthetic, chemically modified double-stranded, small interfering ribonucleic acid (siRNA).

Date: 2023-10-30

Epinephrine to Prevent Postintubation Collapse in Shocked ICU Patients

Status: Completed

Condition: Shock

Interventions: patients will receive epinephrine prepared as 10 ml syringe filled with 10 ml of epinephrine 10 mcg;ml.
prepared by drawing 1ml epinephrine

Date: 2023-10-30

A Phase I Trial of IMA970A Plus Montanide in Combination With Durvalumab (Anti-PD-L1)

Status: Completed

Condition: Hepatocellular Carcinoma

Interventions: IMA970A is a lyophilized multi-peptide vaccine consisting of 17 individual peptides (active pharmaceutical ingredients) and 2 excipients (Poloxamer 33

Date: 2023-10-30

Brief Interventions on Social Media to Reduce Suicide Risk (Intervention 2)

Status: NOT_YET_RECRUITING

Condition: Stigma, Social

Interventions: Participants will be presented with a list of common reasons why people report not wanting to tell other people about their mental health concerns, dr

Date: 2023-10-30

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

Status: NOT_YET_RECRUITING

Condition: Non Hodgkin Lymphoma

Interventions: No intervention

Date: 2023-10-30